News

This is the story of Michele Baldwin, a 45-year-old mother of three who was diagnosed with late-stage cervical cancer.

We're Hiring

GeneFirst Ltd collaborates with Novosanis

Novosanis is proud to announce that as from today its quality system is certified as compliant with the requirements of ISO13485 quality standards for manufacturers of medical devices.

Novosanis, a spin-off of the University of Antwerp, and DDL Diagnostic Laboratory investigated the detection of human papillomavirus (HPV) in first-void urine.

Novosanis, a spin-off of the University of Antwerp, and DDL Diagnostic Laboratory investigated the detection of human papillomavirus (HPV) in first-void urine.

The European Commission granted a “Seal of Excellence” to Novosanis’ project proposal UROSCREEN on the use of Colli-Pee in cervical screening programs.

The European Commission granted a “Seal of Excellence” to Novosanis’ project proposal UROSCREEN on the use of Colli-Pee in cervical screening programs.

De Europese Commissie kende een “Seal of Excellence” toe aan het projectvoorstel UROSCREEN van Novosanis, gericht op het gebruik van Colli-Pee in bevolkingsonderzoek naar...

ANTWERP. POWERED BY CREATIVES. unites award-winning designers during their annual exposition . Novosanis and Voxdale were invited to showcase their innovative health care designs: Colli-Pee...

As the company keeps growing, we're adding new members to our team. Welcome Piotr & Julie!

ANTWERP. POWERED BY CREATIVES. unites award-winning designers during their annual exposition. Novosanis and Voxdale were invited to showcase their innovative designs in regard to health...